The accurate diagnosis of hepatobiliary dysfunction is crucial for effective patient management and treatment. Sulfobromophthalein Sodium (CAS 123359-42-2) is a cornerstone in this diagnostic process, serving as a vital diagnostic aid for hepatobiliary dysfunction. NINGBO INNO PHARMCHEM CO.,LTD., a leading supplier in China, offers this compound to healthcare professionals and researchers worldwide.

The liver plays a central role in processing and eliminating various substances from the body. When liver function is compromised, the body's ability to clear certain compounds, like Sulfobromophthalein Sodium, is impaired. This impairment is typically observed as a delayed removal of the dye from the bloodstream. By measuring the concentration of Sulfobromophthalein Sodium in the plasma over time, clinicians can assess the liver's functional status. This test, often referred to as the sulfobromophthalein retention test, provides objective data that complements other diagnostic procedures.

NINGBO INNO PHARMCHEM CO.,LTD., as a reputable manufacturer in China, is committed to providing Sulfobromophthalein Sodium that meets stringent quality standards. This ensures that the results obtained from its use in clinical settings are reliable and accurate. The ability to purchase this essential diagnostic reagent from a trusted source like NINGBO INNO PHARMCHEM CO.,LTD. is paramount for medical laboratories and diagnostic centers.

Beyond its direct diagnostic use, Sulfobromophthalein Sodium is also employed in experimental studies to understand the mechanisms behind liver diseases and to test potential therapeutic interventions. Its role as an organic anion transporter substrate makes it a valuable tool for exploring cellular transport pathways affected by various pathologies. Through its supply of high-quality Sulfobromophthalein Sodium, NINGBO INNO PHARMCHEM CO.,LTD. supports advancements in both clinical diagnostics and fundamental biomedical research, reinforcing its commitment to improving global health outcomes.